Results 61 to 70 of about 4,322 (154)
Robert D Fechtner1, Paul Harasymowycz2, Donald R Nixon3, Steven D Vold4, Fiaz Zaman5, Julia M Williams6, David A Hollander61Glaucoma Division, University of Medicine and Dentistry New Jersey, Newark, NJ, USA; 2University of Montreal, Montreal, QC, Canada;
Fechtner RD +6 more
doaj
Brimonidine-induced uveitis: The inflammatory aftermath of treatment
We report a rare case of late onset brimonidine-associated granulomatous anterior uveitis in a patient with primary open angle glaucoma (POAG). A 57-year-old female presented with insidious onset blurring of vision, redness, glare, and pain in the right ...
Hitisha Mittal +4 more
doaj +1 more source
Brimonidine Eye Drops within the Reach of Children: A Possible Foe
Brimonidine, a selective alpha-2 adrenergic agonist used for the treatment of open-angle glaucoma, has been shown to cause neurological side effects such as unresponsiveness, lethargy, hypoventilation, and stupor, mimicking opioid toxicity. We report one
Daniela Trotta +5 more
doaj +1 more source
Drug treatment studies are a focal point for identifying novel approaches to reduce myopia progression through basic science research. Here, we investigated the effects of various brimonidine administration routes and concentrations on form-deprivation ...
Aiqun Xiang +8 more
doaj +1 more source
Anna Galanopoulos1, Ivan Goldberg21Senior Visiting Ophthalmologist, South Australian Institute of Ophthalmology and Dept of Ophthalmology and Visual Sciences, University of Adelaide, South Australia; 2Clinical Associate Professor, University of Sydney ...
Anna Galanopoulos, Ivan Goldberg
doaj
Anne J Lee1, Peter McCluskey1,21Department of Ophthalmology, Liverpool Hospital, Liverpool, NSW, Australia; 2Faculty of Medicine, University of New South Wales, Randwick, NSW, AustraliaAbstract: Lowering IOP is the most readily modifiable risk factor to ...
Anne J Lee, Peter McCluskey
doaj
Modification of contact lenses via metal‐organic frameworks for glaucoma treatment
The prevention of blindness from glaucoma requires multiple treatments to lower intraocular pressure. Here, human contact lenses are modified with highly porous metal‐organic frameworks with sustained release of brimonidine for prolonged glaucoma ...
Alexey V. Yaremenko +21 more
doaj +1 more source
TAR-0520, a new candidate in oncodermatology: Results of a phase 1 program in healthy volunteers. [PDF]
Andres P +3 more
europepmc +1 more source
Clinical Microbial Contamination of Multidose Brimonidine: A Prospective Comparison of Benzalkonium Chloride and Purite® Preservatives. [PDF]
Karaca S +6 more
europepmc +1 more source

